Advertisement

Topics

Esanex, Inc. Company Profile

00:55 EST 21st January 2019 | BioPortfolio


News Articles [1 Associated News Articles listed on BioPortfolio]

Esanex Announces Successful End-of-Phase 2 Meeting for SNX-5422 in Neuroendocrine Tumors

-- Agreement reached with FDA on key elements of Phase 3 trial – -- SNX-5422 Granted Orphan Drug Designation -- Esanex, Inc., a clinical stage company develo...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "Esanex, Inc." on BioPortfolio

We have published hundreds of Esanex, Inc. news stories on BioPortfolio along with dozens of Esanex, Inc. Clinical Trials and PubMed Articles about Esanex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Esanex, Inc. Companies in our database. You can also find out about relevant Esanex, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record